Nasal Swab
Nasal Swab is an intervention with 25 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
94.1%
16 of 17 finished
5.9%
1 ended early
3
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants
ORCHARDS-AIR Study
Asymptomatic Flu Project
Clinical Trials (25)
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants
ORCHARDS-AIR Study
Asymptomatic Flu Project
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
Study of the Pathogenesis of Olfactory Disorders in COVID-19
Burden of Influenza at Emergency Department Level : BIED
Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
Role of Nasal Dysbiosis in Parkinson Disease
Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus
Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
Improvement of the Etiological Diagnosis of the Pericarditis
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)
Microbiome in Lung Cancer and Other Malignancies
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Determining the Microbiota Composition of the Middle Meatus in Parkinson's
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 25